Thermo Fisher has outperformed the market with a 420%+ return over the past decade, but its current valuation is high. The company’s ... that can aid further scientific advancement will be ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Evercore ISI increased their price target on shares of Thermo Fisher Scientific from $605.00 to $630.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st.

Barclays raised their target price on Thermo Fisher Scientific from $600.00 to $620.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 15th. Wells Fargo ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

1 Day TMO -0.54% DJIA -0.61% S&P 500 -0.03% Health Care/Life Sciences -0.41% ...

In the third quarter of 2024, Thermo Fisher Scientific reported a revenue miss of approximately $50 million. Despite this shortfall, the company's earnings call was viewed positively by analysts ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, introduced a groundbreaking transmission electron microscope to a packed room of attendees at the recent ...

WILMINGTON, N.C.--(BUSINESS WIRE)--The PPD™ clinical research business of Thermo Fisher Scientific ... site of the global pharmaceutical company AstraZeneca, which has been instrumental in ...